1 study found for:    17234558 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single Dose (4.8 g/Day) in Subjects With Acute Mild to Moderate Ulcerative Colitis
Condition: Colitis, Ulcerative
Intervention: Drug: Delayed and extended release mesalazine

Indicates status has not been verified in more than two years